MAPK
As MAPKs são uma família de proteínas quinases envolvidas em uma variedade de processos celulares, incluindo crescimento, proliferação, diferenciação e respostas ao estresse. A via de sinalização MAPK consiste em várias camadas, incluindo ERK, JNK e p38 MAPKs, cada uma desempenhando papéis distintos na função celular. A desregulação da sinalização MAPK está ligada ao câncer, doenças inflamatórias e distúrbios metabólicos. Na CymitQuimica, oferecemos uma ampla gama de inibidores e ativadores de MAPK para apoiar sua pesquisa em biologia celular, transdução de sinais e mecanismos de doenças.
Foram encontrados 892 produtos de "MAPK"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
K-Ras G12C-IN-4
CAS:K-Ras G12C-IN-4 是一种 KRAS G12C 共价抑制剂。Fórmula:C31H33ClN4O4Pureza:99.00%Cor e Forma:SolidPeso molecular:561.07Ref: TM-T11738
1mg71,00€5mg161,00€10mg236,00€25mg403,00€50mg532,00€100mg783,00€200mg1.054,00€1mL*10mM (DMSO)192,00€Regorafénib N-oxyde (M2)
CAS:Regorafénib N-oxyde M2 is an active metabolite of Regorafenib.
Fórmula:C21H15ClF4N4O4Pureza:98.03% - 98.26%Cor e Forma:SolidPeso molecular:498.81KRAS G12C inhibitor 19
CAS:KRAS G12C inhibitor 19 is a potent KRAS G12C inhibitor that shows anti-tumor activity in cellular assays, and the family inhibits tumor growth.Fórmula:C25H19ClF2N4O3SPureza:97.46%Cor e Forma:SolidPeso molecular:528.96(R)-BI-2852
CAS:(R)-5-hydroxy isoindolin-1-one is an RAS protein inhibitor with antiproliferative and antitumor properties.Fórmula:C31H28N6O2Pureza:97.80%Cor e Forma:SoildPeso molecular:516.59MAP4K4-IN-3
CAS:MAP4K4-IN-3 (Compound 17) may be a viable target for antidiabetic agents, a serine/threonine protein kinase.Fórmula:C15H12ClN5Pureza:98.07%Cor e Forma:SolidPeso molecular:297.74Ref: TM-T11942
5mg44,00€10mg74,00€25mg144,00€50mg222,00€100mg354,00€200mg523,00€500mg797,00€1mL*10mM (DMSO)48,00€Tanzisertib
CAS:Tanzisertib (CC-930) (CC-930) is a potent inhibitor of JNK1/2/3 with IC50s of 61/7/6 nM, respectively, with potential antifibrotic activity.Fórmula:C21H23F3N6O2Pureza:98.66% - 99.28%Cor e Forma:SolidPeso molecular:448.44Ref: TM-T14895
1mg39,00€5mg93,00€10mg138,00€25mg268,00€50mg530,00€100mg705,00€200mg973,00€1mL*10mM (DMSO)92,00€SU3327
CAS:SU3327 (halicin) is a potent, selective and substrate-competitive inhibitor of JNK(IC50 of 0.7 μM).Fórmula:C5H3N5O2S3Pureza:98.39%Cor e Forma:SolidPeso molecular:261.3ARS-1630
CAS:ARS-1630 is a mutant K-ras G12C inhibitor. It is a less active enantiomer of ARS-1620.Fórmula:C21H17ClF2N4O2Pureza:97.78%Cor e Forma:SolidPeso molecular:430.84Ref: TM-T10376
1mg38,00€5mg86,00€10mg112,00€25mg216,00€50mg310,00€100mg408,00€200mg580,00€1mL*10mM (DMSO)88,00€LUT014
CAS:LUT014 is a B-Raf inhibitor (IC50: 11.7 nM) and developed to decrease dose-limiting acneiform lesions associated with EGFR Inhibitors treatment.Fórmula:C27H19F3N8OPureza:99.03%Cor e Forma:SolidPeso molecular:528.49MRTX-1257
CAS:MRTX-1257: selective, irreversible KRAS G12C inhibitor; IC50 of 900 pM; 31% bioavailable in mice; 77% target engagement.Fórmula:C33H39N7O2Pureza:97.3% - 99.07%Cor e Forma:SolidPeso molecular:565.71Ref: TM-T16143
1mg60,00€2mg85,00€5mg124,00€10mg195,00€25mg351,00€50mg512,00€100mg743,00€200mg982,00€1mL*10mM (DMSO)166,00€BI-3406
CAS:BI-3406 is an orally active, highly potent and selective between KRAS and Son of Sevenless 1 (SOS1) interaction inhibitor(IC50 : 6 nM),with anticancer activity.Fórmula:C23H25F3N4O3Pureza:99.2% - 99.66%Cor e Forma:SolidPeso molecular:462.46Ref: TM-T12979
1mg73,00€5mg160,00€10mg250,00€25mg464,00€50mg663,00€100mg919,00€500mg1.833,00€1mL*10mM (DMSO)170,00€INH154
CAS:INH154 is a potent Nek2 and Hec1 binding (INH) inhibitor with IC50s of 120 nM in MB468 cells and 200 nM in Hela cells for INH.Fórmula:C22H24N4OSPureza:99.95%Cor e Forma:SolidPeso molecular:392.52Ref: TM-T11657
2mg34,00€5mg54,00€10mg82,00€25mg136,00€50mg203,00€100mg299,00€200mg416,00€1mL*10mM (DMSO)59,00€PF-3644022
CAS:PF-3644022 is a selective MK2 inhibitor, effective against TNFα (IC50: 5.2 nM, Ki: 3 nM), with anti-inflammatory properties. Also blocks MK3 and PRAK.Fórmula:C21H18N4OSPureza:98.13%Cor e Forma:SolidPeso molecular:374.46Ref: TM-T16501
1mg37,00€5mg111,00€10mg202,00€25mg416,00€50mg620,00€100mg832,00€500mg1.663,00€1mL*10mM (DMSO)187,00€ACBI3
CAS:ACBI3 is a selective pan-KRAS degrader with anticancer activity that degrades oncogenic KRAS. ACBI3 inhibits the growth of most cancer cell lines driven by KRAS mutations.Fórmula:C50H62N14O6S2Pureza:99.24%Cor e Forma:SolidPeso molecular:1019.25ETC-206
CAS:ETC-206 is a selective inhibitor of MNK1 and MNK2 (IC50s: 64 nM and 86 nM).
Fórmula:C25H20N4O2Pureza:99.72% - 99.79%Cor e Forma:SolidPeso molecular:408.45MK2-IN-3 hydrate
CAS:MK2-IN-3 hydrate (MK-2 Inhibitor III) is an orally active, selective, and ATP-competitive inhibitor of MAPKAP-K2 (MK-2) (IC50 of 0.85 nM)Fórmula:C21H18N4O2Pureza:99.58%Cor e Forma:SolidPeso molecular:358.39Ref: TM-T12058
1mg35,00€5mg64,00€10mg93,00€25mg180,00€50mg264,00€100mg369,00€200mg507,00€1mL*10mM (DMSO)78,00€Divarasib
CAS:Divarasib (GDC-6036), an investigational KRAS G12C inhibitor for solid tumors, has an IC50 of <0.01 μM.
Fórmula:C29H32ClF4N7O2Pureza:99.237% - 99.83%Cor e Forma:SolidPeso molecular:622.06CC-90003
CAS:CC-90003 is a selective inhibitor of ERK 1/2. It has antitumor activity.Fórmula:C22H21F3N6O2Pureza:99.42%Cor e Forma:SolidPeso molecular:458.44MRTX0902
CAS:MRTX0902 is an effective and high selective inhibitor of SOS1 with an IC50 of 46 nM and a Ki of 2 nM.Fórmula:C22H24N6OPureza:99.69%Cor e Forma:SolidPeso molecular:388.47(R)-Ketorolac
CAS:(R)-Ketorolac ((+)-Ketorolac) is the R-enantiomer of Ketorolac, with potent analgesic activity.Fórmula:C15H13NO3Pureza:99.55%Cor e Forma:SolidPeso molecular:255.27Ref: TM-T12624
1mg38,00€2mg50,00€5mg84,00€10mg113,00€25mg222,00€50mg313,00€100mg437,00€1mL*10mM (DMSO)93,00€
